triiodothyronine has been researched along with ghrp-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowers, CY; Kraiem, Z; Laron, Z; Sobel, E | 1 |
| Almonte, AS; Bowers, CY; Gil-Ad, I; Hirsch, D; Keret, R; Laron, Z; Pelz, M | 1 |
2 other study(ies) available for triiodothyronine and ghrp-1
| Article | Year |
|---|---|
Growth hormone (GH)-releasing heptapeptide, but not GH-releasing hormone, inhibits thyrotropin-stimulated thyroid hormone secretion and cAMP formation in cultured human thyroid follicles.
Topics: Cells, Cultured; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Growth Hormone-Releasing Hormone; Humans; Oligopeptides; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 1995 |
Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
Topics: Adolescent; Adult; Child; Female; Follicle Stimulating Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Hormones; Humans; Hydrocortisone; Hypopituitarism; Infusions, Intravenous; Luteinizing Hormone; Male; Oligopeptides; Pituitary Gland; Prolactin; Puberty; Radioimmunoassay; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1993 |